Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹14.84 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹14.84 Cr |
| Fresh Issue | ₹14.07 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹26.00-28.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | MONOPHARMA |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Unistone Capital Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 4,000 shares and in multiples thereof
Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products.
The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac - Diabetic medicines, and cosmocare products.
Mono Pharmacare works with contract manufacturers to manufacture pharmaceutical products to sell them under their brand name DLS Export. The company acquired DLS Export in 2022, for an aggregate consideration of ₹ 609 lakhs, in order to grow its product portfolio in selected therapeutic areas.
As on February 28, 2023, the company has over 168 pharmaceutical companies as their distributors and stockists and also, and served over 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To meet the working capital requirements | 8.98 |
| 2 | General corporate purposes; and | 3.66 |
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 62.57 | 14.38 | 11.22 | 8.72 |
| Total Income | 37.10 | 28.38 | 11.69 | |
| Profit After Tax | 0.35 | 0.10 | 0.02 | |
| NET Worth | 4.28 | 3.70 | 2.02 | |
| Reserves and Surplus | 1.32 | |||
| Total Borrowing | 6.44 | 6.08 | 6.33 | |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | 9.01% |
| ROCE | 10.34% |
| Debt / Equity | 2.92% |
| RoNW | 9.01% |
| PAT Margin | 2.11% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 1.99 | |
| P/E (x) | 40 | |
| Promoter Holding | 81.02% | |
| Market Cap | ₹49.47 Cr. | |
